• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

RPS support controlled drugs emergency supply proposal

8th April 2020 by PIP editor Leave a Comment

 

A letter has been sent from the UK Home Secretary to the Advisory Council on the Misuse of Drugs to advise on COVID-19 emergency measures to enable the supply of controlled drugs.

 

The letter from the Rt Hon Priti Patel MP, asks the Advisory Council on the Misuse of Drugs to advise on three potential measures that would enable the supply of medicines containing controlled substances in light of the COVID-19 outbreak.

 

Commenting on the proposal, RPS President Sandra Gidley said:

 

“Pharmacists have been working very effectively to ensure the safe and effective supply of controlled drugs to the public for many years now.

 

“During these challenging times, individuals may find it more difficult to access their repeat prescriptions from prescribing teams because of staff shortages from illness or self-isolation, so this seems to be a sensible and pragmatic move.

 

“The proposals that have been put forward are for the supply of controlled drugs in exceptional circumstances. They are likely to be used on occasion to make supplies to patients who have been receiving certain controlled drugs as part of on-going treatment. Pharmacists would use their professional judgement in line with safeguarding rules before making any supply, as well as working with other healthcare professionals involved in the care of the patient.

 

“We support this move and will provide guidance to the profession to provide clarity and maintain high standards of supply, once the necessary legislation is passed.

 

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  Covid-19 community pharmacy vaccine campaign begins

Filed Under: COVID-19, News Tagged With: Coronavirus, PIP news

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

Pharmacies should be allowed to supply rapid antibody tests

Admiration for community pharmacy in Scotland

Community pharmacy isn’t set up to deliver interventions at scale

No national Scottish pharmacy flu service a missed opportunity

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.